anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.02.21 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 18.02.21 | Rio Tinto buy | Jefferies & Company Inc. | |
| 18.02.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 18.02.21 | BAT buy | Goldman Sachs Group Inc. | |
| 17.02.21 | BAT Outperform | Credit Suisse Group | |
| 17.02.21 | BAT buy | Goldman Sachs Group Inc. | |
| 17.02.21 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 17.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.02.21 | BAT overweight | JP Morgan Chase & Co. | |
| 17.02.21 | Rio Tinto buy | Jefferies & Company Inc. | |
| 17.02.21 | BAT Hold | Jefferies & Company Inc. | |
| 17.02.21 | Rio Tinto Neutral | UBS AG | |
| 17.02.21 | BAT Outperform | RBC Capital Markets | |
| 17.02.21 | Unilever Neutral | JP Morgan Chase & Co. | |
| 17.02.21 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.02.21 | GSK Sell | Deutsche Bank AG | |
| 16.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 16.02.21 | Prudential buy | UBS AG | |
| 16.02.21 | HSBC buy | Goldman Sachs Group Inc. | |
| 15.02.21 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 15.02.21 | Prudential buy | Deutsche Bank AG | |
| 15.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 12.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 12.02.21 | Shell (ex Royal Dutch Shell) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 12.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 12.02.21 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 12.02.21 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 11.02.21 | AstraZeneca Neutral | UBS AG | |
| 11.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. |